Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Open Posted
- Opportunity number
- RFA-DA-26-034
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $300,000
Opportunity facts
- Assistance listings
-
- 93.279 Drug Use and Addiction Research Programs
- 93.855 Allergy and Infectious Diseases Research
- 93.839 Blood Diseases and Resources Research
- 93.233 National Center on Sleep Disorders Research
- 93.838 Lung Diseases Research
- 93.837 Cardiovascular Diseases Research
- 93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- Funding instrument
- Grant
- Categories
-
- Health
- Education
- Eligible applicants
-
- City/Township Governments
- Public or Indian Housing Auth.
- Independent School Districts
- Small Businesses
- Special District Governments
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- County Governments
- Tribal Organizations (Not Federally Recognized)
- For Profit Organizations
- Other
- Higher Education Inst. (Private)
- Non-501(c)(3) Nonprofits
- Tribal Governments (Federally Recognized)
- State Governments
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health is soliciting applications for basic research on the deleterious effects of acute exposure to ultra-potent synthetic opioids and related pathophysiological consequences, with applications due November 18, 2027. Clinical trials are not eligible under this R01 mechanism.
Eligible applicants include a broad range of organizations: higher education institutions (public and private), state and local governments, special district governments, Indian housing authorities, independent school districts, nonprofits (501(c)(3) and non-501(c)(3)), tribal organizations and governments (federally and non-federally recognized), small businesses, for-profit organizations, and other entities. Additionally eligible are Alaska Native and Native Hawaiian serving institutions, HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, faith-based and community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. Non-domestic entities and non-domestic components of U.S. organizations are not eligible.
The program supports research addressing acute exposure to ultra-potent synthetic opioids including fentanyl, carfentanil, and nitazenes, as well as their combinations such as fentanyl and xylazine. Research on persistent and delayed pathophysiological effects following acute exposure is also within scope.
The opportunity is assigned to five parent grant programs under the National Institutes of Health: Drug Use and Addiction Research Programs (CFDA 93.279), Allergy and Infectious Diseases Research (CFDA 93.855), Cardiovascular Diseases Research (CFDA 93.837), Lung Diseases Research (CFDA 93.838), and National Center on Sleep Disorders Research (CFDA 93.233). Award ceiling, floor, expected number of awards, period of performance, place of performance, and specific evaluation criteria are not specified in the available materials. Applicants must follow standard NIH R01 application procedures using FORMS-I research instructions.
Synopsis
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Files
| File | Type | Posted |
|---|---|---|
| RFA-DA-26-034-Full-Announcement.html | HTML file | |
| PKG00288830.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity